Therapeutic Asset Ratings
13,157 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Docetaxel
Adenocarcinoma
University of Chicago
P2
B
(63)
DOXORUBICIN
Indolent B-Cell Non-Hodgkin Lymphoma
Fate Therapeutics
P2
B
(63)
Durvalumab
Digestive System Cancer
M.D. Anderson Cancer Center
P2
B
(63)
Durvalumab
Luminal B Breast Carcinoma
Jules Bordet Institute
P2
B
(63)
Epirubicin
Marginal Zone Lymphoma
University of Ulm
P2
B
(63)
ETOPOSIDE
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P2
B
(63)
ETOPOSIDE
Indolent B-Cell Non-Hodgkin Lymphoma
David Bond, MD
P2
B
(63)
Everolimus
Grade III Glioma
Nationwide Children's Hospital
P2
B
(63)
Ezabenlimab
Metastatic Malignant Neoplasm
Boehringer Ingelheim
P2
B
(63)
FILGRASTIM
Primary Effusion Lymphoma
City of Hope Medical Center
P2
B
(63)
FILGRASTIM
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
University of Washington
P2
B
(63)
FILGRASTIM
Gliosarcoma
Leland Metheny
P2
B
(63)
Fludarabine
Hemoglobinopathy
Masonic Cancer Center, University of Minnesota
P2
B
(63)
Fludarabine
Pancreatic Ductal Adenocarcinoma
Beijing Biotech
P2
B
(63)
Gm-Csf
Refractory Malignant Neoplasm
Second Affiliated Hospital of Soochow University
P2
B
(63)
Gm-Csf
Ductal Breast Carcinoma In Situ
Mayo Clinic
P2
B
(63)
Gm-Csf
Diffuse Large B-Cell Lymphoma
Medical College of Wisconsin
P2
B
(63)
Gm-Csf
Hodgkins Lymphoma
Medical College of Wisconsin
P2
B
(63)
Ibrutinib
MALT Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
P2
B
(63)
Ibrutinib
Burkitt Lymphoma
National Cancer Institute (NCI)
P2
B
(63)
Ibrutinib
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
P2
B
(63)
Ibrutinib
Nodal Marginal Zone B-Cell Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
P2
B
(63)
Ibrutinib
Prolymphocytic Leukemia
Fred Hutchinson Cancer Center
P2
B
(63)
Ibrutinib
Lymphoplasmacytic Lymphoma
National Cancer Institute (NCI)
P2
B
(63)
Ibrutinib
Central Nervous System Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P2
B
(63)
Showing 976 to 1000 of 13,157 assets
Previous
Page 40 of 527
Next